Literature DB >> 23820270

Colitis and colon cancer in WASP-deficient mice require helicobacter species.

Deanna D Nguyen1, Suresh Muthupalani, Jeremy A Goettel, Michelle A Eston, Melissa Mobley, Nancy S Taylor, Amanda McCabe, Romela Marin, Scott B Snapper, James G Fox.   

Abstract

BACKGROUND: Wiskott-Aldrich syndrome protein-deficient patients and mice are immunodeficient and can develop inflammatory bowel disease. The intestinal microbiome is critical to the development of colitis in most animal models, in which Helicobacter spp. have been implicated in disease pathogenesis. We sought to determine the role of Helicobacter spp. in colitis development in Wiskott-Aldrich syndrome protein-deficient (WKO) mice.
METHODS: Feces from WKO mice raised under specific pathogen-free conditions were evaluated for the presence of Helicobacter spp., after which a subset of mice were rederived in Helicobacter spp.-free conditions. Helicobacter spp.-free WKO animals were subsequently infected with Helicobacter bilis.
RESULTS: Helicobacter spp. were detected in feces from WKO mice. After rederivation in Helicobacter spp.-free conditions, WKO mice did not develop spontaneous colitis but were susceptible to radiation-induced colitis. Moreover, a T-cell transfer model of colitis dependent on Wiskott-Aldrich syndrome protein-deficient innate immune cells also required Helicobacter spp. colonization. Helicobacter bilis infection of rederived WKO mice led to typhlitis and colitis. Most notably, several H. bilis-infected animals developed dysplasia with 10% demonstrating colon carcinoma, which was not observed in uninfected controls.
CONCLUSIONS: Spontaneous and T-cell transfer, but not radiation-induced, colitis in WKO mice is dependent on the presence of Helicobacter spp. Furthermore, H. bilis infection is sufficient to induce typhlocolitis and colon cancer in Helicobacter spp.-free WKO mice. This animal model of a human immunodeficiency with chronic colitis and increased risk of colon cancer parallels what is seen in human colitis and implicates specific microbial constituents in promoting immune dysregulation in the intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820270      PMCID: PMC4082694          DOI: 10.1097/MIB.0b013e318295fd8f

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  49 in total

1.  Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice.

Authors:  Christoph Klein; Deanna Nguyen; Ching-Hui Liu; Atsushi Mizoguchi; Atul K Bhan; Hiroaki Miki; Tadaomi Takenawa; Fred S Rosen; Fred W Alt; Richard C Mulligan; Scott B Snapper
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

2.  Case report of an unclassified microaerophilic bacterium associated with gastroenteritis.

Authors:  S Romero; J R Archer; M E Hamacher; S M Bologna; R F Schell
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

3.  Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.

Authors:  E Y Chin; C A Dangler; J G Fox; D B Schauer
Journal:  Comp Med       Date:  2000-12       Impact factor: 0.982

4.  Characterization of an unclassified microaerophilic bacterium associated with gastroenteritis.

Authors:  J R Archer; S Romero; A E Ritchie; M E Hamacher; B M Steiner; J H Bryner; R F Schell
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

5.  Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice.

Authors:  Deanna D Nguyen; Marc-Andre Wurbel; Jeremy A Goettel; Michelle A Eston; Osub S Ahmed; Romela Marin; Elisa K Boden; Eduardo J Villablanca; Helena Paidassi; Vineet Ahuja; Hans-Christian Reinecker; Edda Fiebiger; Adam Lacy-Hulbert; Bruce H Horwitz; J Rodrigo Mora; Scott B Snapper
Journal:  Gastroenterology       Date:  2012-06-15       Impact factor: 22.682

Review 6.  The immunology of mucosal models of inflammation.

Authors:  Warren Strober; Ivan J Fuss; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Authors:  Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Sabine Escobar; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

8.  Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.

Authors:  Sophie Dupuis-Girod; Jacques Medioni; Elie Haddad; Pierre Quartier; Marina Cavazzana-Calvo; Françoise Le Deist; Geneviève de Saint Basile; Jean Delaunay; Klaus Schwarz; Jean-Laurent Casanova; Stephane Blanche; Alain Fischer
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

9.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.

Authors:  Susan E Erdman; Theofilos Poutahidis; Michal Tomczak; Arlin B Rogers; Kathleen Cormier; Benjamin Plank; Bruce H Horwitz; James G Fox
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more
  13 in total

1.  Isolation of Helicobacter spp. from mice with rectal prolapses.

Authors:  Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; James G Fox
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

2.  Helicobacter saguini, a Novel Helicobacter Isolated from Cotton-Top Tamarins with Ulcerative Colitis, Has Proinflammatory Properties and Induces Typhlocolitis and Dysplasia in Gnotobiotic IL-10-/- Mice.

Authors:  Z Shen; A Mannion; M T Whary; S Muthupalani; A Sheh; Y Feng; G Gong; P Vandamme; H R Holcombe; B J Paster; J G Fox
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

3.  Helicobacter Infection Significantly Alters Pregnancy Success in Laboratory Mice.

Authors:  Tara C Bracken; Caitlin A Cooper; Zil Ali; Ha Truong; Julie M Moore
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-05-01       Impact factor: 1.232

4.  Effects of Colonization of Gnotobiotic Swiss Webster Mice with Helicobacter bilis.

Authors:  Mark T Whary; Chuanwu Wang; Catherine F Ruff; Mallory J DiVincenzo; Caralyn Labriola; Lillian Ge; Yan Feng; Zhongming Ge; Vasu Bakthavatchalu; Suresh Muthupalani; Bruce H Horwitz; James G Fox
Journal:  Comp Med       Date:  2020-04-29       Impact factor: 0.982

5.  Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Authors:  Todd Atherly; Curtis Mosher; Chong Wang; Jesse Hostetter; Alexandra Proctor; Meghan W Brand; Gregory J Phillips; Michael Wannemuehler; Albert E Jergens
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

6.  Novel Helicobacter species H.japonicum isolated from laboratory mice from Japan induces typhlocolitis and lower bowel carcinoma in C57BL/129 IL10-/- mice.

Authors:  Zeli Shen; Yan Feng; Sureshkumar Muthupalani; Alexander Sheh; Lenzie E Cheaney; Christian A Kaufman; Guanyu Gong; Bruce J Paster; James G Fox
Journal:  Carcinogenesis       Date:  2016-09-21       Impact factor: 4.944

7.  Gnotobiotic and Conventional Mouse Systems to Support Microbiota Based Studies.

Authors:  Richard Lavin; Nicholas DiBenedetto; Vladimir Yeliseyev; Mary Delaney; Lynn Bry
Journal:  Curr Protoc Immunol       Date:  2018-04-16

8.  Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma.

Authors:  Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; Frauke Drees; Zhongming Ge; Yan Feng; Xiaowei Chen; Guanyu Gong; Karan K Nagar; Timothy C Wang; Frank B Gertler; James G Fox
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

9.  In Vivo Chronic Stimulation Unveils Autoreactive Potential of Wiskott-Aldrich Syndrome Protein-Deficient B Cells.

Authors:  Maria Carmina Castiello; Francesca Pala; Lucia Sereni; Elena Draghici; Donato Inverso; Aisha V Sauer; Francesca Schena; Elena Fontana; Enrico Radaelli; Paolo Uva; Karla E Cervantes-Luevano; Federica Benvenuti; Pietro L Poliani; Matteo Iannacone; Elisabetta Traggiai; Anna Villa; Marita Bosticardo
Journal:  Front Immunol       Date:  2017-05-02       Impact factor: 7.561

10.  Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019.

Authors:  Yuming Chong; Chang Han; Ji Li; Xiao Long
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.